Whitehawk Therapeutics (WHWK) Interest Coverage Ratio (2010 - 2026)
Whitehawk Therapeutics' (WHWK) quarterly Interest Coverage Ratio came in at 2.92 in Q1 2026, up 98.1% year-on-year from 1.47 in Q1 2025, and down 101.16% on a QoQ basis from 251.38 in Q4 2025.
Whitehawk Therapeutics (WHWK) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 17 years of Interest Coverage Ratio data on file, last reported at 2.92 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 98.1% year-over-year to 2.92 in Q1 2026; TTM through Mar 2026 was 15.21, a 82.47% increase from a year earlier, with the FY2025 full-year figure at 35.67, down 6346.0% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 2.92, down from 251.38 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for WHWK reached as high as 251.38 in Q4 2025 and fell as low as 310.77 in Q4 2023.
- Historically, Interest Coverage Ratio has averaged 79.17 across 5 years, with a median of 50.6 in 2022.
- Across the five-year window, Interest Coverage Ratio sank 1157.99% in 2022 and jumped 691.68% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 271.44 in 2022, then dropped by 14.49% to 310.77 in 2023, then soared by 86.33% to 42.49 in 2024, then soared by 691.68% to 251.38 in 2025, then slumped by 101.16% to 2.92 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 2.92 in Q1 2026, 251.38 in Q4 2025, and 36.26 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Whitehawk Therapeutics | 34.18 Mn | 34.18 Mn | - | -2.92 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.92 |
| Dec 31, 2025 | 251.38 |
| Sep 30, 2025 | -36.26 |
| Jun 30, 2025 | -119.28 |
| Mar 31, 2025 | -153.72 |
| Dec 31, 2024 | -42.49 |
| Sep 30, 2024 | -46.25 |
| Jun 30, 2024 | -55.66 |
| Mar 31, 2024 | -154.86 |
| Dec 31, 2023 | -310.77 |
| Sep 30, 2023 | -11.30 |
| Jun 30, 2023 | -11.47 |
| Mar 31, 2023 | -135.69 |
| Dec 31, 2022 | -271.44 |
| Sep 30, 2022 | -187.95 |
| Jun 30, 2022 | -6.60 |
| Mar 31, 2022 | -50.60 |
| Dec 31, 2021 | -29.64 |
| Sep 30, 2021 | -319.82 |
| Jun 30, 2021 | -1.76 |